Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting
Overview
Overview
Journal
Clin Infect Dis
Publisher
Oxford University Press
Specialty
Infectious Diseases
Date
2022 Feb 8
PMID
35134144
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
In a cohort of mostly Central American immigrants with confirmed neurocysticercosis (NCC), 3.1% were confirmed positive for Chagas disease (CD). The majority were diagnosed with NCC before age 50. Entry to care for NCC is an opportunity for early detection and possible treatment for CD in those from endemic areas.
References
1.
Requena-Mendez A, Bussion S, Aldasoro E, Jackson Y, Angheben A, Moore D
. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet Glob Health. 2017; 5(4):e439-e447.
DOI: 10.1016/S2214-109X(17)30073-6.
View
2.
Forsyth C, Manne-Goehler J, Bern C, Whitman J, Hochberg N, Edwards M
. Recommendations for Screening and Diagnosis of Chagas Disease in the United States. J Infect Dis. 2021; 225(9):1601-1610.
PMC: 9071346.
DOI: 10.1093/infdis/jiab513.
View
3.
Serpa J, White Jr A
. Neurocysticercosis in the United States. Pathog Glob Health. 2012; 106(5):256-60.
PMC: 4005108.
DOI: 10.1179/2047773212Y.0000000028.
View
4.
Castro-Sesquen Y, Saldana A, Patino Nava D, Bayangos T, Paulette Evans D, DeToy K
. Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area. Clin Infect Dis. 2020; 72(9):e303-e310.
PMC: 8096267.
DOI: 10.1093/cid/ciaa1101.
View
5.
Rocha M, Nunes M, Ribeiro A
. Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:159-66.
DOI: 10.1590/s0074-02762009000900022.
View